Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-28 Sale | 2024-04-01 9:28 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 860 | $4.6495 | $3,999 | 71,908 (Direct) | View |
2024-03-25 Sale | 2024-03-27 6:57 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 1,350 | $4.67 | $6,305 | 72,768 (Direct) | View |
2023-06-07 Sale | 2023-06-09 4:25 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 9,273 | $12.03 | $111,526 | 60,118 (Direct) | View |
2023-06-06 Sale | 2023-06-07 4:55 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 1,200 | $12.04 | $14,448 | 69,391 (Direct) | View |
2022-03-15 Sale | 2022-03-16 4:04 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 533 | $11.3 | $6,023 | 46,041 (Direct) | View |
2021-11-15 Sale | 2021-11-17 7:46 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 20,000 | $27.33 | $546,613 | 533 (Direct) | View |
2021-08-16 Sale | 2021-08-20 4:24 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 15,000 | $33.99 | $509,886 | 20,533 (Direct) | View |
2021-05-17 Sale | 2021-05-18 5:53 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 15,000 | $32.71 | $490,710 | 35,533 (Direct) | View |
2020-12-28 Sale | 2020-12-30 5:10 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 34,744 | $33.92 | $1,178,456 | 105,383 (Direct) | View |
2020-12-22 Sale | 2020-12-28 4:40 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 57,979 | $33.46 | $1,939,934 | 429,712 (Direct) | View |
2020-12-21 Sale | 2020-12-22 4:37 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 40,000 | $33.08 | $1,323,200 | 243,183 (Direct) | View |
2020-12-16 Sale | 2020-12-18 8:29 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 17,277 | $34.94 | $603,692 | 204,596 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-01 Option Award | 2024-03-04 9:06 pm | N/A 2034-02-28 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 99,000 | $0 | 159,118 (Direct) | View |
2023-01-30 Option Award | 2023-02-01 9:46 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 121,650 | $0 | 167,691 (Direct) | View |
2022-01-18 Exercise | 2022-01-20 4:42 pm | N/A 2032-01-17 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 115,000 | $0 | 115,000 (Direct) | View |
2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 15,978 | $1.637 | 219,827 (Direct) | View |
2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A 2027-06-14 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 46,041 | $0 | 219,827 (Direct) | View |
2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 19,590 | $2.062 | 219,827 (Direct) | View |
2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 10,473 | $2.425 | 219,827 (Direct) | View |
2021-02-08 Option Award | 2021-02-10 9:05 pm | N/A 2031-02-08 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 125,000 | $0 | 125,000 (Direct) | View |
2020-12-28 Exercise | 2020-12-30 5:10 pm | N/A 2029-03-29 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 48 | $0 | 105,383 (Direct) | View |
2020-12-28 Exercise | 2020-12-30 5:10 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 48 | $2.062 | 105,383 (Direct) | View |
2020-12-22 Exercise | 2020-12-28 4:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 17,682 | $1.637 | 429,712 (Direct) | View |
2020-12-22 Exercise | 2020-12-28 4:40 pm | N/A 2027-12-04 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 57,979 | $0 | 429,712 (Direct) | View |
2020-12-22 Exercise | 2020-12-28 4:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 30,809 | $2.062 | 429,712 (Direct) | View |
2020-12-23 Exercise | 2020-12-28 4:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 9,488 | $2.425 | 429,712 (Direct) | View |
2020-12-21 Exercise | 2020-12-22 4:37 pm | N/A 2029-12-16 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 40,000 | $0 | 243,183 (Direct) | View |
2020-12-21 Exercise | 2020-12-22 4:37 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 40,000 | $2.425 | 243,183 (Direct) | View |
2020-12-16 Exercise | 2020-12-18 8:29 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 8,956 | $1.637 | 204,596 (Direct) | View |
2020-12-16 Exercise | 2020-12-18 8:29 pm | N/A 2027-06-14 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 17,277 | $0 | 204,596 (Direct) | View |
2020-12-18 Exercise | 2020-12-18 8:29 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 8,321 | $2.062 | 204,596 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 08:09 am | N/A 2030-06-18 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 41,240 | $0 | 41,240 (Direct) | View |
Ownership | 2020-06-18 9:48 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 0 | $0 | 419,827 (Direct) | View |